The affected lots are being recalled due to an unexpected impurity in the manufacturers’ active pharmaceutical ingredient (API). Finally, the patient answers the question "I've been short of breath" using a 0-4 scale, 0 being none and the most severe. Contadina Pizzetas and Del Monte Veggieful Bites. Keywords provided by University of Minnesota: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Why Should I Register and Submit Results? … The latest recall comes after Torrent Pharmaceuticals expanded its recall of losartan … Smolander J, Bruchfeld A. Participants in this arm will receive a placebo treatment. The new lot is … FDA expands blood pressure drug recall for fifth time this year.  (Clinical Trial), Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor), Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization, 18 Years and older   (Adult, Older Adult), Minneapolis, Minnesota, United States, 55415, M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States, 55455, Rochester, Minnesota, United States, 55415. A total of 16 lots have been recalled, all at the consumer level. Participants will collect oropharyngeal swabs every third day for the duration of study participation. DRUG NAME: Losartan Potassium 50mg & 100mg Tablets . The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. 2020 Jul 13;117. pii: 20110. Outcome is reported as the mean number of emergency department and clinic presentations combined per participant in each arm. Update - Recall expanded. Physical score is computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. endstream endobj startxref The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. Genetic and Rare Diseases Information Center. On July 2, 2020, it was announced that Major Pharmaceuticals issued a consumer-level recall on Metformin Hydrochloride Extended-Release 500mg Tablets, 10×10 Unit Dose with NDC #00904-5794-61. %PDF-1.6 %���� Patients fill out a 12 question survey which is then scored by a clinician or researcher. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, … Please remove one or more studies before adding more. Patients fill out a 12 question survey which is then scored by a clinician or researcher. Outcome reported as the percent of participants in each arm who require hospital admission by day 15 following randomization. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04311177. Losartan may also be used for purposes not listed in this medication guide. UPDATE - Teva expands its voluntary recall of losartan Update [6/12/2019] Teva Pharmaceuticals is expanding its voluntary recall to include seven additional lots of losartan potassium tablets (three lots of 50 mg strength and four lots of 100 mg strength) labeled by Golden State Medical Supply. This prompted the first recall of valsartan medicines due to the presence of a cancer-causing substance called N-nitrosodimethylamine (NDMA) in July 2018.

A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Check out what's clicking on Foxnews.comTorrent Pharmaceuticals Limited said its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, are affected by the recall.The ingredient detected was identified as N-Methylnitrosobutyric acid (NMBA), a known animal and potential human carcinogen.